Get Your Personalized Supplement StackSupplement Stack Quiz

Active Hexose Correlated Compound

Also known as: AHCC, Active Hexose Correlated Compound

Overview

Active Hexose Correlated Compound (AHCC) is a fermented extract derived from the mycelia of Basidiomycete mushrooms, primarily the shiitake mushroom (_Lentinula edodes_). It is a complex mixture of polysaccharides, amino acids, lipids, and minerals, predominantly oligosaccharides, including partially acetylated α-1,4-glucans. AHCC is promoted as an immune system modulator, particularly for immunocompromised individuals, such as cancer and HIV patients. Research suggests that AHCC modulates both innate and adaptive immune responses, enhancing tumor immune surveillance and increasing resistance to infections. It is available in capsule or powder form and is generally taken orally. While research is ongoing, current evidence supports its potential as a supplementary treatment to improve immune function and clinical outcomes.

Benefits

AHCC has demonstrated several evidence-based benefits, primarily related to immune modulation. It significantly increases natural killer (NK) cell activity, enhancing the body's ability to target and eliminate infected or cancerous cells. AHCC also enhances dendritic cell function, which is crucial for initiating adaptive immune responses. Animal studies suggest that AHCC can delay tumor development and improve tumor immune surveillance. Furthermore, AHCC supplementation has been shown to increase survival rates in response to various infectious agents, including influenza virus and bacterial infections. Clinical trials have indicated improved prognosis and quality of life in liver cancer patients and improved clinical status in HIV-infected patients with pulmonary tuberculosis. These benefits are observed in both short-term and long-term studies, with significant improvements in immune parameters and clinical outcomes.

How it works

AHCC modulates both innate and adaptive immune responses by activating key immune cells. It enhances the activity of natural killer (NK) cells, dendritic cells, and T cells, which are critical for immune surveillance and response. AHCC interacts with pattern recognition receptors, such as Toll-Like Receptors (TLRs), on immune cells, triggering downstream signaling pathways that promote immune activation. The partially acetylated α-1,4-glucans in AHCC are believed to be the active compounds responsible for these interactions. By enhancing the phagocytic system and stimulating systemic immune responses, AHCC boosts the body's defense mechanisms against infections and tumors.

Side effects

AHCC is generally considered safe with minimal adverse effects reported in clinical trials. No significant common side effects (greater than 5%) have been consistently reported across studies. Data on uncommon (1-5%) and rare (less than 1%) side effects are limited, but no major concerns have been raised in the available literature. AHCC has been analyzed for potential interactions with cytochrome P450 enzymes, and no significant interactions were found. However, caution is advised for individuals with known sensitivities or allergies to mushroom extracts. Pregnant or breastfeeding women should consult healthcare providers before using AHCC due to limited data on its safety in these populations. While AHCC appears to have a favorable safety profile, it is essential to monitor for any adverse reactions and discontinue use if they occur.

Dosage

Typical dosages of AHCC range from 3 to 6 grams per day, with 3 grams per day being a common dose in many studies. The minimum effective dose is not well established, but clinical studies have used doses within this range. There is no established maximum safe dose, but doses up to 6 grams per day have been used without significant adverse effects. AHCC is typically available in capsule or powder form and is taken orally. No specific timing recommendations are available, but it is generally taken as part of a daily regimen. The absorption of AHCC is not extensively studied, but oral administration is effective. No specific cofactors are required for AHCC supplementation. It is important to consult with a healthcare provider to determine the appropriate dosage based on individual health status and needs.

FAQs

Is AHCC safe to use?

AHCC is generally considered safe, but individuals with sensitivities or allergies to mushroom extracts should exercise caution. Pregnant or breastfeeding women should consult healthcare providers before use.

When and how should I take AHCC?

There are no specific timing recommendations; it can be taken as part of a daily regimen. AHCC is typically available in capsule or powder form and is taken orally.

What results can I expect from taking AHCC?

Users can expect enhanced immune function and potentially improved resistance to infections. In immunocompromised patients, AHCC may improve clinical outcomes as a supplementary treatment.

Is AHCC a cure for diseases?

No, AHCC is not a cure for any disease. It is a supplement to support immune function and may improve clinical outcomes when used as part of a comprehensive treatment plan.

Research Sources

https://www.naturalmedicinejournal.com/journal/active-hexose-correlated-compound-ahcc-and-immune-outcomes-humans-review – This systematic review provides a comprehensive overview of the safety and efficacy of AHCC. It consolidates data from multiple clinical trials and expert opinions, highlighting AHCC's immune-modulating effects and potential benefits in various clinical contexts. The review uses a validated grading rationale, ensuring a high-quality assessment of the available evidence.
https://pubmed.ncbi.nlm.nih.gov/16362410/ – This prospective cohort study examined the effects of AHCC supplementation in 44 liver cancer patients. The study found that AHCC supplementation at 6 grams per day was associated with improved prognosis and quality of life, suggesting a potential benefit for cancer patients. While the sample size was small, the clinical outcomes were significant.
https://pubmed.ncbi.nlm.nih.gov/23931762/ – This animal study investigated the effects of AHCC treatment on tumor development in C57BL/6 mice. The study found that AHCC treatment delayed tumor development and enhanced tumor immune surveillance by regulating both innate and adaptive immune responses. These findings suggest that AHCC has significant immune-modulating effects that could be beneficial in cancer prevention and treatment.
https://www.teikyomedicaljournal.com/volume/TMJ/44/03/the-active-hexose-correlated-compound-ahcc-effect-on-clinical-outcome-of-pulmonary-tuberculosis-in-hiv-infected-patients-610e29bb4c305.pdf – This clinical trial assessed the impact of AHCC supplementation on HIV-infected patients with pulmonary tuberculosis. The study demonstrated that AHCC supplementation improved clinical status, reduced symptoms, and improved body weight and appetite in these patients. These results suggest that AHCC can be a valuable adjunct therapy for improving clinical outcomes in this specific population.
https://academic.oup.com/nutritionreviews/article-abstract/66/9/526/1855379?redirectedFrom=fulltext&login=false – This article abstract discusses the potential benefits of AHCC in supporting immune function. It highlights AHCC's ability to modulate immune responses and improve clinical outcomes in various conditions. The abstract provides a concise overview of the key findings from relevant studies, emphasizing the importance of AHCC as a dietary supplement for immune support.